Stephen L. Rose

1.3k total citations
33 papers, 1.1k citations indexed

About

Stephen L. Rose is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Stephen L. Rose has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Reproductive Medicine. Recurrent topics in Stephen L. Rose's work include Cancer survivorship and care (7 papers), Epigenetics and DNA Methylation (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). Stephen L. Rose is often cited by papers focused on Cancer survivorship and care (7 papers), Epigenetics and DNA Methylation (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). Stephen L. Rose collaborates with scholars based in United States, Australia and Canada. Stephen L. Rose's co-authors include Erin S. Costanzo, Richard E. Buller, Barrie Anderson, Susan K. Lutgendorf, Sarah Bradley, Michael J. Goodheart, Muthusamy Kunnimalaiyaan, Songwon Seo, Barry R. DeYoung and Bruce A. Smith and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.

In The Last Decade

Stephen L. Rose

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen L. Rose United States 20 530 364 228 192 142 33 1.1k
Dorothea Fischer Germany 18 275 0.5× 323 0.9× 241 1.1× 152 0.8× 79 0.6× 71 1.2k
Michaela Onstad United States 10 158 0.3× 304 0.8× 145 0.6× 177 0.9× 239 1.7× 24 736
Haruko Hiraike Japan 18 475 0.9× 211 0.6× 193 0.8× 132 0.7× 118 0.8× 54 1.2k
You Li China 20 295 0.6× 125 0.3× 260 1.1× 102 0.5× 42 0.3× 68 1.2k
David J. Hunter United States 11 353 0.7× 235 0.6× 313 1.4× 227 1.2× 188 1.3× 14 1.4k
Julie Martyn Australia 14 357 0.7× 109 0.3× 135 0.6× 51 0.3× 106 0.7× 23 767
Joseph P. McElroy United States 21 343 0.6× 125 0.3× 42 0.2× 231 1.2× 71 0.5× 56 1.0k
Jorge Carvajal C Chile 16 207 0.4× 140 0.4× 80 0.4× 140 0.7× 242 1.7× 108 1.3k
Yifeng Wang China 21 490 0.9× 145 0.4× 131 0.6× 230 1.2× 56 0.4× 77 1.2k
Volkan Turan Türkiye 21 361 0.7× 260 0.7× 1.1k 4.7× 53 0.3× 128 0.9× 87 1.7k

Countries citing papers authored by Stephen L. Rose

Since Specialization
Citations

This map shows the geographic impact of Stephen L. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Rose more than expected).

Fields of papers citing papers by Stephen L. Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Rose. The network helps show where Stephen L. Rose may publish in the future.

Co-authorship network of co-authors of Stephen L. Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen L. Rose. A scholar is included among the top collaborators of Stephen L. Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen L. Rose. Stephen L. Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoeve, Elizabeth S. Ver, Meredith E. Rumble, Jessica Gorzelitz, et al.. (2024). Biobehavioral predictors of mood, pain, fatigue, and insomnia in endometrial cancer survivors. Gynecologic Oncology. 191. 265–274. 4 indexed citations
2.
Simpson, Peter T., Sunil R. Lakhani, Mostafa Kamal Masud, et al.. (2024). Clinically Boosting Cancer Molecular Targeted Radioligand Therapies with Innovative Nanomaterials. ChemNanoMat. 11(1).
3.
Vetter, Monica Hagan, Paola A. Gehrig, Koji Matsuo, et al.. (2020). Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?. Gynecologic Oncology. 159(2). 354–358. 6 indexed citations
4.
Spencer, Ryan, et al.. (2020). A digital media attention diversion improves mood and fear in patients receiving chemotherapy for recurrent gynecologic malignancies: results of a randomized trial. International Journal of Gynecological Cancer. 30(4). 525–532. 5 indexed citations
5.
Rose, Stephen L., et al.. (2018). Multiple concurrent unusual neoplasms presenting in a patient with familial adenomatous polyposis: A case report and review of the literature. Human Pathology Case Reports. 14. 41–46. 1 indexed citations
6.
Rumble, Meredith E., et al.. (2015). Circadian actigraphic rest–activity rhythms following surgery for endometrial cancer: A prospective, longitudinal study. Gynecologic Oncology. 137(3). 448–455. 15 indexed citations
7.
Rumble, Meredith E., et al.. (2015). Biopsychosocial predictors of pain among women recovering from surgery for endometrial cancer. Gynecologic Oncology. 140(2). 301–306. 27 indexed citations
8.
Alberts, David S., John A. Blessing, Lisa M. Landrum, et al.. (2012). Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study. Gynecologic Oncology. 127(3). 451–455. 51 indexed citations
9.
Seo, Songwon, et al.. (2012). The role of appendectomy for mucinous ovarian neoplasms. American Journal of Obstetrics and Gynecology. 208(1). 46.e1–46.e4. 48 indexed citations
10.
Rose, Stephen L., et al.. (2010). Notch 1 signaling is active in ovarian cancer. Gynecologic Oncology. 117(1). 130–133. 83 indexed citations
11.
Rose, Stephen L.. (2010). Where Once There Was Color. Obstetrics and Gynecology. 117(1). 143–144. 1 indexed citations
12.
Lickliter, Jason D., G. A. Smith, Matthew Burge, et al.. (2010). Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent. British Journal of Cancer. 103(5). 597–606. 23 indexed citations
13.
Rose, Stephen L.. (2009). Notch Signaling Pathway in Ovarian Cancer. International Journal of Gynecological Cancer. 19(4). 564–566. 40 indexed citations
14.
Bradford, Leslie, et al.. (2009). Primary angiosarcoma of the ovary complicated by hemoperitoneum: a case report and review of the literature. Archives of Gynecology and Obstetrics. 281(1). 145–150. 22 indexed citations
15.
Watts, George S., et al.. (2008). DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage. BMC Medical Genomics. 1(1). 47–47. 60 indexed citations
16.
DiFeo, Analisa, Goutham Narla, Olga Camacho‐Vanegas, et al.. (2006). E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor. Oncogene. 25(44). 6026–6031. 58 indexed citations
17.
DiFeo, Analisa, Goutham Narla, Olga Camacho‐Vanegas, et al.. (2006). Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination. Clinical Cancer Research. 12(12). 3730–3739. 96 indexed citations
18.
Rose, Stephen L., Matthew P. Fitzgerald, Michael J. Hitchler, et al.. (2006). Epigenetic regulation of maspin expression in human ovarian carcinoma cells. Gynecologic Oncology. 102(2). 319–324. 44 indexed citations
19.
Costanzo, Erin S., Susan K. Lutgendorf, Sarah Bradley, Stephen L. Rose, & Barrie Anderson. (2005). Cancer Attributions, Distress, and Health Practices Among Gynecologic Cancer Survivors. Psychosomatic Medicine. 67(6). 972–980. 65 indexed citations
20.
Stone, Pamela, Michael J. Goodheart, Stephen L. Rose, et al.. (2003). The influence of microvessel density on ovarian carcinogenesis. Gynecologic Oncology. 90(3). 566–571. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorothea Fischer Breakdown of academic impact, for papers by Michaela Onstad Breakdown of academic impact, for papers by Haruko Hiraike Breakdown of academic impact, for papers by You Li Breakdown of academic impact, for papers by David J. Hunter Breakdown of academic impact, for papers by Julie Martyn Breakdown of academic impact, for papers by Joseph P. McElroy Breakdown of academic impact, for papers by Jorge Carvajal C Breakdown of academic impact, for papers by Yifeng Wang Breakdown of academic impact, for papers by Volkan Turan
Rankless by CCL
2026